(1 year ago)
Commons ChamberHow would a future pandemic be different from the previous ones in terms of strategic stocks of protective equipment, and vaccine research, manufacture and distribution, should we be visited with such a disaster by a Chinese wet market or even a laboratory?
My right hon. Friend tempts me to talk about the origins of covid. I will simply highlight that the World Health Organisation continues its investigation, and we are very much supportive of that.
As for what we are doing differently, the key thing is to move from the establishment of the disease to the vaccine with the 100-day taskforce. We have also overhauled our governance structures. For example, we have split the long-term risks and the short-term risks by creating a totally separate unit that deals with long-term risks, which is headed by a head of resilience. That will enable the Government to deal with the long-term risks but also focus on the short-term challenges. When I was at Porton Down last week, I saw the kind of investment that the UK Health Security Agency is making in precisely this area, whether in capacity to test vaccines’ effectiveness or to test the testing equipment. I am confident that while there is more to do, as I set out in my statement, we continue to improve our performance.
(1 year, 3 months ago)
Commons ChamberWithout referring to any specific case, may I gently remind the Government that their initial response to the ISC’s substantial and wide-ranging report on the national security threat from China, published just two months ago, was to suggest that our findings might be out of date? Will the Deputy Prime Minister therefore confirm that the full Government response, when it comes—we gather it is coming very soon—will set out specific steps to address the threat of Chinese interference, particularly within our democratic system?
The short answer is yes. I have reviewed the response, and I am content that it does exactly that. It will be with my right hon. Friend shortly.